• Agilent Technologies Inc., of Santa Clara, Calif., will acquire Dako Denmark A/S, a cancer diagnostic company based in Glostrup, Denmark, for $2.2 billion, the largest acquisition in Agilent's history. Agilent seeks to boost its revenue and presence in life sciences. Dako produces antibodies, reagents, instruments and software for the cancer diagnostic market, and collaborates with major pharmaceutical companies to develop new companion diagnostic products.